Ratings by TD Cowen (Joseph Thome)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Mirum Pharmaceuticals | MIRM | Maintain | (N/A) |
|
Details | ||
| 2/25/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 1/12/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2025 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | PTC Therapeutics | PTCT | Maintain | (N/A) |
|
Details | ||
| 10/31/2025 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2025 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2025 | Mirum Pharmaceuticals | MIRM | New Coverage | Buy (N/A) |
73.93 (86.21) |
16.61% | Details | |
| 9/8/2025 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 7/23/2025 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2025 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2025 | Amylyx Pharmaceuticals inc. | AMLX | New Coverage | Buy (N/A) |
4.90 (13.85) |
182.65% | Details | |
| 5/13/2025 | Bright Minds Biosciences Inc. | DRUG | New Coverage | Buy (N/A) |
32.49 (76.87) |
136.6% | Details | |
| 5/7/2025 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 5/7/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2025 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2024 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
20.20 (28.34) |
40.3% | Details | |
| 10/25/2024 | Marinus Pharmaceuticals | MRNS | Downgrade | Hold (Buy) |
1.69 (0.55) |
-67.46% | Details | |
| 10/11/2024 | Allakos Inc. | ALLK | Maintain | Hold (N/A) |
|
Details | ||
| 10/10/2024 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2024 | Prime Medicine | PRME | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2024 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 9/4/2024 | Metagenomi Inc | MGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Entrada Therapeutics | TRDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Chimerix | CMRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Adverum Biotechnologies | ADVM | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2024 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2024 | Adverum Biotechnologies | ADVM | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2024 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
25.44 (30.24) |
18.87% | Details | |
| 6/26/2024 | Allakos Inc. | ALLK | Maintain | Hold (N/A) |
|
Details | ||
| 6/24/2024 | Entrada Therapeutics | TRDA | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2024 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2024 | Aerovate Therapeutics Inc | AVTE | Downgrade | Hold (Buy) |
24.62 (2.68) |
-89.11% | Details | |
| 6/17/2024 | Alkermes | ALKS | New Coverage | Buy (N/A) |
24.50 (28.63) |
16.86% | Details | |
| 6/3/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2024 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
5.75 (4.01) |
-30.26% | Details | |
| 3/5/2024 | Metagenomi Inc | MGX | New Coverage | Buy (N/A) |
12.04 (1.48) |
-87.71% | Details | |
| 3/1/2024 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 12/11/2023 | Intra-Cellular Therapies | ITCI | New Coverage | Buy (N/A) |
60.29 (131.87) |
118.73% | Details | |
| 12/8/2023 | Cerevel Therapeutics | CERE | Downgrade | Hold (Buy) |
36.93 (44.96) |
21.74% | Details | |
| 12/5/2023 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2023 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 10/18/2023 | Evelo Biosciences Inc | EVLO | Downgrade | Hold (Buy) |
2.91 (0.00) |
-100% | Details | |
| 5/24/2023 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 4/10/2023 | Cerevel Therapeutics | CERE | New Coverage | Buy (N/A) |
24.47 (44.96) |
83.74% | Details | |
| 12/12/2022 | Acrivon Therapeutics Inc | ACRV | New Coverage | Buy (N/A) |
12.50 (1.55) |
-87.6% | Details | |
| 12/12/2022 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
36.20 (41.94) |
15.86% | Details | |
| 11/14/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2022 | Third Harmonic Bio | THRD | New Coverage | Buy (N/A) |
20.01 (5.38) |
-73.11% | Details | |
| 9/9/2022 | Allakos Inc. | ALLK | Maintain | Hold (N/A) |
|
Details | ||
| 8/19/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2022 | Epizyme | EPZM | Downgrade | Hold (Buy) |
0.95 (1.47) |
54.74% | Details | |
| 6/21/2022 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 6/17/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 5/24/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 5/16/2022 | Chimerix | CMRX | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | Evelo Biosciences Inc | EVLO | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2022 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Evelo Biosciences Inc | EVLO | Maintain | Buy (Buy) |
|
Details | ||
| 3/21/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Allakos Inc. | ALLK | Maintain | Hold (Hold) |
|
Details | ||
| 3/1/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Evelo Biosciences Inc | EVLO | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2022 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 2/23/2022 | PTC Therapeutics | PTCT | Maintain | Hold (Hold) |
|
Details | ||
| 2/23/2022 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (Buy) |
|
Details | ||
| 2/22/2022 | Esperion Therapeutics | ESPR | Maintain | Buy (Buy) |
|
Details | ||
| 2/7/2022 | Evelo Biosciences Inc | EVLO | Maintain | Buy (Buy) |
|
Details | ||
| 1/31/2022 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
86.02 (13.44) |
-84.38% | Details | |
| 1/27/2022 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (Buy) |
|
Details | ||
| 12/22/2021 | Allakos Inc. | ALLK | Downgrade | Hold (Buy) |
84.39 (0.33) |
-99.61% | Details | |
| 12/8/2021 | Allakos Inc. | ALLK | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2021 | Entrada Therapeutics | TRDA | New Coverage | Buy (N/A) |
30.46 (12.58) |
-58.7% | Details | |
| 11/10/2021 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2021 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2021 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | Aerovate Therapeutics Inc | AVTE | New Coverage | Buy (N/A) |
14.23 (24.62) |
73.01% | Details | |
| 7/15/2021 | Allakos Inc. | ALLK | New Coverage | Buy (N/A) |
76.53 (0.33) |
-99.57% | Details | |
| 6/15/2021 | Marinus Pharmaceuticals | MRNS | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2021 | Chimerix | CMRX | New Coverage | Buy (N/A) |
8.22 (8.54) |
3.89% | Details | |
| 4/19/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2021 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 10/28/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2020 | PTC Therapeutics | PTCT | Maintain | Hold (N/A) |
|
Details | ||
| 7/1/2020 | Marinus Pharmaceuticals | MRNS | New Coverage | Buy (N/A) |
2.54 (0.55) |
-78.35% | Details | |
| 4/27/2020 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2020 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
60.04 (162.33) |
170.37% | Details | |
| 12/3/2019 | uniQure BV | QURE | New Coverage | Buy (N/A) |
54.78 (14.27) |
-73.95% | Details |
